BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18086592)

  • 1. A 4-month, open-label study evaluating the efficacy of eflornithine 11.5% cream in the treatment of unwanted facial hair in women using TrichoScan.
    Hoffmann R
    Eur J Dermatol; 2008; 18(1):65-70. PubMed ID: 18086592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women.
    Hamzavi I; Tan E; Shapiro J; Lui H
    J Am Acad Dermatol; 2007 Jul; 57(1):54-9. PubMed ID: 17270315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial.
    Smith SR; Piacquadio DJ; Beger B; Littler C
    Dermatol Surg; 2006 Oct; 32(10):1237-43. PubMed ID: 17034372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for unwanted facial hair.
    Shapiro J; Lui H
    Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):1-4. PubMed ID: 16408139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaniqa--eflornithine 13.9% cream.
    Shapiro J; Lui H
    Skin Therapy Lett; 2001 Apr; 6(7):1-3, 5. PubMed ID: 11376395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant eflornithine to maintain IPL-induced hair reduction in women with facial hirsutism: a randomized controlled trial.
    Vissing AC; Taudorf EH; Haak CS; Philipsen PA; Haedersdal M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):314-9. PubMed ID: 26507926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eflornithine cream for facial hair reduction.
    Med Lett Drugs Ther; 2000 Oct; 42(1089):96. PubMed ID: 11015161
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism.
    Jackson J; Caro JJ; Caro G; Garfield F; Huber F; Zhou W; Lin CS; Shander D; Schrode K;
    Int J Dermatol; 2007 Sep; 46(9):976-81. PubMed ID: 17822506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of terminal and vellus non-pigmented hairs with an optical/bipolar radiofrequency energy source-with and without pre-treatment using topical aminolevulinic acid.
    Goldberg DJ; Marmur ES; Hussain M
    J Cosmet Laser Ther; 2005 Mar; 7(1):25-8. PubMed ID: 16020213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical eflornithine hydrochloride improves the effectiveness of standard laser hair removal for treating pseudofolliculitis barbae: a randomized, double-blinded, placebo-controlled trial.
    Xia Y; Cho S; Howard RS; Maggio KL
    J Am Acad Dermatol; 2012 Oct; 67(4):694-9. PubMed ID: 22226431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess salt and pepper hair treated with a combination of laser hair removal and topical eflornithine HCl.
    Ganger LK; Hamzavi IH
    J Drugs Dermatol; 2006 Jun; 5(6):544-5. PubMed ID: 16774107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair.
    Wolf JE; Shander D; Huber F; Jackson J; Lin CS; Mathes BM; Schrode K;
    Int J Dermatol; 2007 Jan; 46(1):94-8. PubMed ID: 17214730
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidance for the management of hirsutism.
    Dawber RP
    Curr Med Res Opin; 2005 Aug; 21(8):1227-34. PubMed ID: 16083532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial and abdominal hair growth in hirsutism: a computerized evaluation.
    Hines G; Moran C; Huerta R; Folgman K; Azziz R
    J Am Acad Dermatol; 2001 Dec; 45(6):846-50. PubMed ID: 11712028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of unwanted facial hair.
    Shenenberger DW; Utecht LM
    Am Fam Physician; 2002 Nov; 66(10):1907-11. PubMed ID: 12469966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichoscopic changes in hair during treatment of hirsutism with 1064-nm neodymium:yttrium-aluminum-garnet laser.
    Mohamed EE; Ahmed AM; Tawfik KM; Ibrahim SM
    J Cosmet Dermatol; 2016 Mar; 15(1):31-5. PubMed ID: 26223429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of TrichoScan technology as a fully-automated tool for evaluation of hair growth parameters.
    Gassmueller J; Rowold E; Frase T; Hughes-Formella B
    Eur J Dermatol; 2009; 19(3):224-31. PubMed ID: 19220982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unwanted facial hair removal with laser treatment improves quality of life of patients.
    Maziar A; Farsi N; Mandegarfard M; Babakoohi S; Gorouhi F; Dowlati Y; Firooz A
    J Cosmet Laser Ther; 2010 Feb; 12(1):7-9. PubMed ID: 20020837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichoscan: what is new?
    Hoffmann R
    Dermatology; 2005; 211(1):54-62. PubMed ID: 15983438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.
    Hoffmann R
    Eur J Dermatol; 2001; 11(4):362-8. PubMed ID: 11399546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.